CAS 2226735-55-1 appears in our catalog under these names: (S)-6-(4-(5-(3,5-Difluorophenyl)-4,5-dihydro-1H-pyrazole-1-carbonyl)piperidin-1-yl)pyrimidine-4-carbonitrile, 99+%, GSK547, GSK547 , GSK'547, GSK547, 99.92%. Offered by: BLDpharm, Chemat, TargetMol, GLPBio, Biosynth. Available pack sizes: 25mg, 50mg, 100mg, 250mg, 1mg, 5mg, 10mg, 2mg.
GSK547 (GSK'547) is a highly selective and potent inhibitor of receptor-interacting serine/threonine protein kinase 1 (RIPK1), inhibits macrophage-mediated adaptive immune tolerance in pancreatic cancer.
Source: ChEBI
| Molecular formula | C20H18F2N6O |
|---|---|
| Molecular weight | 396.4 g/mol |
| IUPAC name | 6-[4-[(3S)-3-(3,5-difluorophenyl)-3,4-dihydropyrazole-2-carbonyl]piperidin-1-yl]pyrimidine-4-carbonitrile |
| InChIKey | SJVGFKBLUYAEOK-SFHVURJKSA-N |
| SMILES | C1CN(CCC1C(=O)N2[C@@H](CC=N2)C3=CC(=CC(=C3)F)F)C4=NC=NC(=C4)C#N |
Computed by PubChem (NCBI)